مرور Volume 17, Issue 1 بر اساس موضوع "ALK"
در حال نمایش موارد 1 - 1 از 1
-
EGFR Mutations, ROS1, and ALK Rearrangements in Iranian Non-Small Cell Lung Cancer Patients
(Tehran, Iranian Blood and Cancer Society, 2025-03-01)Background: Driver mutations, particularly in the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and ROS1 genes, are prevalent in non-small cell lung cancer (NSCLC) and significantly influence ...



